breakout, page-46

To Dleb,
Noone know how high is high, and how low is low. There 's ever too late to get in when the signal come. Look at EXT, I sold it at over $1.20. It then goes down to 80c. It then went back up to $1.5, then over $2.0. I told my friend to get in, since my money is locking up sonewhere, but everyon scares because it was below $1.0 before. It then went up every day to over $5. One day it made a big drop to $3.8 (if I remember correctly) in a day, still no one dared to get in and now it is over $6 (without any anouncement).

To Others,
I kept thinking over and over again about the last announcement and try to figure out what was wrong with it. I 'm guessing that the 800 dose is safe but the 1200 dose is not acceptable. This means Avexa can only stay with what it has 800 dose and can not go and improve further for their ATC. This means, it can continue phase III and may be able to market it, but not a great drug, which in turn means can not compete with other already exist treatment. However, that is just my guess. DYOR.